Prevention

How do infection preventionists navigate the many—and often contradictory—requirements that fighting the COVID-19 pandemic has brought upon them?

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the great news about Ebola in Uganda. She also covers COVID-19 news, and what it has to do with the Clash of the Titans.

What do clinicians, infection preventionists, and environmental hygiene personnel do when faced with rare infectious diseases? Matt Pullen, MD, gives ICT® readers a tutorial.

Have the CDC and EPA given enough correct guidance on how to use cleaning products during the COVID-19 pandemic, or is it “fundamentally flawed”?

How should health care workers, especially infection preventionists, give constructive criticism in their positions?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 6, 2023.

In this third installment of 3, Infection Control Today® continues the one father's story of how sepsis can enter central lines and how it affects the entire family.

The public expects infectious disease experts to know how to protect them—and themselves—from getting ill from infectious diseases, including COVID-19. So, what happens when the infectious disease specialist gets ill herself?

Even during the COVID-19 pandemic, infection preventionists, nurses, environmental services personnel, and other health care workers cannot forget about C auris.

A recent study attempted to estimate the transmission of SARS-CoV-2 from humans to their pets and identify the risk factors, including food and water bowls and human-animal contact.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses infectious diseases as the new year begins.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 30, 2022.

Here are the top 5 video interviews from Infection Control Today for 2022.

Here is the most popular ICT® article of 2022.

Read about the sterilization process of eye instruments and devices.

This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 4th, 3rd, and 2nd most popular.

Kevin Kavanagh, MD, discusses the continued concerns about COVID-19 vaccine efficacy reduction and what he believes should be done to protect against the further spread.

This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 7th, 6th, and 5th.

December is International Sharps Injury Prevention Awareness Month. This month serves as a reminder to health care workers, waste management workers, laboratory staff, and others to practice sharp safety and follow safety protocols.

This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 10th, 9th, and 8th.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 24, 2022.

In this first installment of 3, Infection Control Today® presents a personal story of how sepsis can enter central lines, and how it affects the entire family.

The best disinfectant needs to be fast-acting and remain wet for the entire contact time in a single application. What else is required?

FDA approved this intravenous tocilizumab (Actemra) for hospitalized adults with COVID-19.

Infection Control Today® talks to Shannon Simmons, DHSc, MPH, CIC, about her work with the APIC's Cleaning, Disinfection, Sterilization Conference and her position as an ambulatory infection preventionist.

A study from Canada suggests that not being vaccinated for COVID-19 could mean an individual is at higher risk for an automobile accident. What if it is from brain damage from contracting COVID-19?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 15, 2022.

Immunocompromised individuals are at higher risk of contracting COVID-19. But do the current treatments protect them? If not, then what needs to be done?

Saskia v. Popescu covers the news about COVID-19 cases, Ebola, and cholera in the week before Christmas, 2022.

With many of the new COVID-19 vaccines not as effective against the new variants, reducing their spread without pharmaceuticals is even more critical.